| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0eb3e981dd7eddec8673b4e19b35708b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2021cafa8df7b0dec20ae2c7682f639 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24234
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10 |
| filingDate |
2020-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c9c5b51143aa5c0408ae7ef313ad07d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1611a37053a0c53e24df48b388e04057
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a49d82f7010c70d6037163c84f9d9d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3858b133674c45f663bfe23cc9aa56b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8093e10ccf912a6be6a8d6357035569f |
| publicationDate |
2021-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021064197-A1 |
| titleOfInvention |
Isolated polypeptide and polypeptide complexes for prevention, alleviation and/or treatment of hcv infections |
| abstract |
The present invention relates to an isolated polypeptide comprising an amino acid sequence of a soluble fraction of envelope protein 2 (E2) from hepatitis C virus; and an inverted amino acid sequence of a soluble fraction of envelope protein 1 (s1E) from hepatitis C virus. The invention further relates to a polypeptide complex comprising more than one isolated polypeptide and to a composition comprising an isolated polypeptide and/or a polypeptide complex. The invention also relates to the isolated polypeptide, the polypeptide complex and the composition for use as a medicament, in particular for use in prevention, alleviation or treatment of hepatitis C virus infections and associated diseases. |
| priorityDate |
2019-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |